CTRI/2024/01/062079尚未招募1 期
A study to investigate the antiretroviral drug in Ayurveda. - Nill
Satyananda yoga and Ayurveda Research institute Motihari0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients diagnosis to be HIV Positive
排除标准
- •Taking immunomodulatory
- •Patient of antiretroviral Therapy
- •Pregnancy or lactation
研究者
相似试验
进行中（未招募）
1 期
Essai pilote évaluant un traitement antirétroviral associant le MK-0518, le darunavir/ritonavir (TMC114/r) et l’etravirine (TMC125) chez les patients infectés par le VIH-1, en échec virologique et porteurs de virus multi-résistants. - TRIOEUCTR2007-000670-23-FRAgence nationale de recherches sur le sida et les hépatites virales. ANRS
已完成
不适用
Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trialISRCTN48682427Ministry of Health (Brazil)
已完成
不适用
A clinical trial of R-CHOP with antiretroviral therapy for newly diagnosed CD20 positive AIDS-related non-Hodgkin lymphomaewly diagnosed CD20 positive AIDS-related non-Hodgkin lymphomaJPRN-UMIN000001452AIDS Clinical Center42
进行中（未招募）
1 期
Initiation of first-line antiretroviral treatment with TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the first clinical contact in France: Trial IMEA 055 – FASTHIV positive age > 18 years -newly diagnosed HIV-infected individual evidenced by any tests -antiretroviral-treatment naive -negative urine pregnancy test -willing to sign an informed written consent– -regular health insurance -willing to provide two distinct contact information (telephone number and/or email) in order to be easily reached if needed between Day 0 and Day 7EUCTR2019-000812-27-FRIMEA110
招募中
不适用
igeria PrEP Demonstration StudyHIV/AIDSPACTR201605001602542ational Agency for the Control of AIDS600